Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Filspari (sparsentan)
.
Show all posts
Showing posts with label
Filspari (sparsentan)
.
Show all posts
Wednesday, February 7, 2024
FDA Grants Accelerated Approval to Filspari (sparsentan) for the Reduction of Proteinuria in IgA Nephropathy
›
Travere Therapeutics, Inc. (Nasdaq: TVTX) announced the U.S. Food and Drug Administration (FDA) approval to Filspari ™ (sparsentan) to re...
›
Home
View web version
